Financing Strategy
Trustful dialog.
Issuer | CHEPLAPHARM Arzneimittel GmbH |
Amount | EUR 500,000,000.00 |
Release | 11 February 2020 |
Maturity | 11 February 2027 |
Ranking | Senior Secured |
Coupon | 3.50% |
Interest payment dates | 15 February / 15 August - semi-annually |
ISIN | XS2112973107 |
WKN | A254SJ |
Governing Law | New York Law |
Issuer | CHEPLAPHARM Arzneimittel GmbH |
Amount | EUR 575,000,000.00 |
Release | 15 October 2020 |
Maturity | 15 January 2028 |
Ranking | Senior Secured |
Coupon | 4.375% |
Interest payment dates | 15 January / 15 July - semi-annually |
ISIN | XS2243548273 |
WKN | A3H2YL |
Governing Law | New York Law |
Issuer | CHEPLAPHARM Arzneimittel GmbH |
Amount | USD 500,000,000.00 |
Release | 15 October 2020 |
Maturity | 15 January 2028 |
Ranking | Senior Secured |
Coupon | 5.500% |
Interest payment dates | 15 January / 15 July - semi-annually |
ISIN | USD1T29ZAB81 |
WKN | A3H2YN |
Governing Law | New York Law |
Issuer | CHEPLAPHARM Arzneimittel GmbH |
Amount | EUR 980,000,000.00 |
Release | 12 July 2018 |
Maturity | 11 July 2025 |
Ranking | Senior Secured |
Coupon | EURIBOR (0%Floor) +3,50% |
Interest periods | one, two, three or six months |
Governing Law | English Law |
Agent | Deutsche Bank Luxembourg S.A. |